Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs-Reference-Cited by-同舟云学术

Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs

Published:2008-07-16 Issue:12 Volume:23 Page:3762-3766
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

de Miguel D.,Garcia-Suarez J.,Martin Y.,Gil-Fernandez J. J.,Burgaleta C.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/23/12/3762/5337630/gfn503.pdf

Reference15 articles.

1. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma

2. Understanding and Managing Methotrexate Nephrotoxicity

3. Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure

4. A method for estimating the probability of adverse drug reactions

5. Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches;Frontiers in Nephrology;2024-08-09

2. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate;Scientific Reports;2024-04-27

3. Risk factors for acute kidney injury after high-dose methotrexate therapy: a single-center study and narrative review;European Journal of Clinical Pharmacology;2023-04-15

4. Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis;ClinicoEconomics and Outcomes Research;2023-03

5. Novel Aspects of Leukemia Pharmacogenomics;Leukemia;2022-10-16